Annals of Oncology

News

Back to baked potato? Or is it another "laboratory finding"?
Ann Oncol 2002 13: 1163-1164; doi:10.1093/annonc/mdf329 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Editorials

S. Rao and D. Cunningham

Advanced pancreatic cancer—5 years on
Ann Oncol 2002 13: 1165-1168; doi:10.1093/annonc/mdf313 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

M. L. Nasi and M. Castiglione

Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?
Ann Oncol 2002 13: 1169-1171; doi:10.1093/annonc/mdf312 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Review

Get checked abstract J. van der Zee

Heating the patient: a promising approach?
Ann Oncol 2002 13: 1173-1184; doi:10.1093/annonc/mdf280 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Gastrointestinal tumors

Get checked abstract M. Ducreux, P. Rougier, J.-P. Pignon, J.-Y. Douillard, J.-F. Seitz, R. Bugat, J.-F. Bosset, Y. Merouche, J.-L. Raoul, M. Ychou, A. Adenis, F. Berthault-Cvitkovic, and M. Luboinski

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
Ann Oncol 2002 13: 1185-1191; doi:10.1093/annonc/mdf197 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract J. Taïeb, E. Mitry, V. Boige, P. Artru, J. Ezenfis, T. Lecomte, M. C. Clavero-Fabri, J. N. Vaillant, P. Rougier, and M. Ducreux

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
Ann Oncol 2002 13: 1192-1196; doi:10.1093/annonc/mdf201 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract S. Hegewisch-Becker, Y. Gruber, A. Corovic, U. Pichlmeier, D. Atanackovic, A. Nierhaus, and D. K. Hossfeld

Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study
Ann Oncol 2002 13: 1197-1204; doi:10.1093/annonc/mdf216 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Gynecologic tumors

Get checked abstract G. Ferrandina, L. Lauriola, G. F. Zannoni, A. Fagotti, F. Fanfani, F. Legge, N. Maggiano, M. Gessi, S. Mancuso, F. O. Ranelletti, and G. Scambia

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
Ann Oncol 2002 13: 1205-1211; doi:10.1093/annonc/mdf207 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Duenas-Gonzalez, C. Lopez-Graniel, A. Gonzalez-Enciso, A. Mohar, L. Rivera, A. Mota, R. Guadarrama, G. Chanona, and J. de la Garza

Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies
Ann Oncol 2002 13: 1212-1219; doi:10.1093/annonc/mdf196 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Breast cancer

Get checked abstract K. D. Miller, W. Gradishar, L. Schuchter, J. A. Sparano, M. Cobleigh, N. Robert, H. Rasmussen, and G. W. Sledge

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer
Ann Oncol 2002 13: 1220-1224; doi:10.1093/annonc/mdf199 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract E. A. Perez, L. Geeraerts, V. J. Suman, A. A. Adjei, A. T. Baron, A. K. Hatfield, N. Maihle, J. C. Michalak, S. A. Kuross, J. W. Kugler, J. M. Lafky, and J. N. Ingle

A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer
Ann Oncol 2002 13: 1225-1235; doi:10.1093/annonc/mdf222 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract H. M. Verkooijen, G. Fioretta, C. de Wolf, G. Vlastos, J. Kurtz, B. Borisch, P. Schäfer, A. Spiliopoulos, A. P. Sappino, R. Renella, B. Pittet, J. Schmid de Gruneck, Y. Wespi, I. Neyroud-Caspar, and C. Bouchardy

Management of women with ductal carcinoma in situ of the breast: a population-based study
Ann Oncol 2002 13: 1236-1245; doi:10.1093/annonc/mdf194 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Head and neck cancer

Get checked abstract C.-F. Hwang, C.-L. Cho, C.-C. Huang, J.-S. Wang, Y.-L. Shih, C.-Y. Su, and H.-W. Chang

Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy
Ann Oncol 2002 13: 1246-1251; doi:10.1093/annonc/mdf215 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract R. K. C. Ngan, H. H. Y. Yiu, W. H. Lau, S. Yau, F. Y. Cheung, T. M. Chan, C. H. Kwok, C. Y. Chiu, S. K. Au, W. Foo, C. K. Law, and K. C. Tse

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study
Ann Oncol 2002 13: 1252-1258; doi:10.1093/annonc/mdf200 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Urogenital tumors

Get checked abstract G. Batist, F. Patenaude, P. Champagne, D. Croteau, C. Levinton, C. Hariton, B. Escudier, and E. Dupont

Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels
Ann Oncol 2002 13: 1259-1263; doi:10.1093/annonc/mdf195 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Hematologic malignancies

Get checked abstract G. M. Mead, M. R. Sydes, J. Walewski, A. Grigg, C. S. Hatton, P. Norbert, C. Guarnaccia, M. S. Lewis, J. McKendrick, S. P. Stenning, and D. Wright

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study
Ann Oncol 2002 13: 1264-1274; doi:10.1093/annonc/mdf253 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract E. Maartense, S. le Cessie, H. C. Kluin-Nelemans, P. M. Kluin, S. Snijder, P. W. Wijermans, and E. M. Noordijk

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’s lymphoma registry
Ann Oncol 2002 13: 1275-1284; doi:10.1093/annonc/mdf198 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract E. Weidmann, S.-Z. Kim, A. Rost, H. Schuppert, G. Seipelt, D. Hoelzer, and P. S. Mitrou

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin’s lymphoma
Ann Oncol 2002 13: 1285-1289; doi:10.1093/annonc/mdf189 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Visco, L. J. Medeiros, D. Jones, T. Smith, M. A. Rodriguez, P. McLaughlin, J. Romaguera, F. Cabanillas, and A. H. Sarris

Primary cutaneous non-Hodgkin’s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement
Ann Oncol 2002 13: 1290-1299; doi:10.1093/annonc/mdf206 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Phase I and pharmacokinetics

Get checked abstract I. Sekine, N. Yamamoto, H. Kunitoh, Y. Ohe, T. Tamura, T. Kodama, and N. Saijo

Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs
Ann Oncol 2002 13: 1300-1306; doi:10.1093/annonc/mdf202 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Clinical trials

Get checked abstract H. E. M. van Luijn, A. W. Musschenga, R. B. Keus, W. M. Robinson, and N. K. Aaronson

Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members
Ann Oncol 2002 13: 1307-1313; doi:10.1093/annonc/mdf209 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Clinical case

Get checked abstract J.-M. Gornet, E. Savier, F. Lokiec, E. Cvitkovic, J. -L. Misset, and F. Goldwasser

Exacerbation of oxaliplatin neurosensory toxicity following surgery
Ann Oncol 2002 13: 1315-1318; doi:10.1093/annonc/mdf254 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Letters to the Editor

K. Wheatley and N. Ives

Adjuvant interferon for melanoma
Ann Oncol 2002 13: 1319-1320; doi:NULL [Extract] [FREE Full Text] [PDF] [Request Permissions]  

C. J. A. Punt and A. M. M. Eggermont

Reply to "Adjuvant interferon for melanoma", by K. Wheatley & N. Ives
Ann Oncol 2002 13: 1320; doi:10.1093/annonc/mdf297 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

S. Tanneberger, I. Malavasi, P. Mariano, F. Pannuti, and E. Strocchi

Planning palliative or terminal care: the dilemma of doctors’ prognoses in terminally ill cancer patients
Ann Oncol 2002 13: 1320-1322; doi:10.1093/annonc/mdf223 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

D. Tassinari, M. Maltoni, and D. Amadori

Reply: Prediction of survival in terminally ill cancer patients: why we cannot avoid an evidence-based palliative medicine
Ann Oncol 2002 13: 1322-1323; doi:NULL [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Book reviews

E. G. E. de Vries and P. H. B. Willemse

B.A. Chabner, D.L. Longo (eds.) Cancer Chemotherapy and Biotherapy: Principles and Practice
Ann Oncol 2002 13: 1325; doi:10.1093/annonc/mdf237 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.